CDC Confirms Parainfluenza Virus and HMPV Are Elevated Nationally — Here's What Parents Need to Know About Croup Right Now

The U.S. Centers for Disease Control and Prevention (CDC) has confirmed nationally elevated activity for both parainfluenza virus (PIV) and human metapneumovirus (HMPV) as of its June 12, 2026 update, sparking renewed concern for parents as croup cases surge in children under 5. While PIV is a recognized culprit behind the distinctive 'barking' cough of croup, the often-overlooked HMPV is also a significant contributor to pediatric respiratory illness, highlighting a persistent diagnostic blind spot in U.S. healthcare. This elevated viral activity extends what is typically considered the peak respiratory season, with HMPV showing an extended active period into June, though it is now in decline. The challenge for the pediatric healthcare system is exacerbated by HMPV underdiagnosis; a May 2026 epidemiological study estimated HMPV causes over 200,000 U.S. hospitalizations annually, often missed by standard respiratory testing panels that prioritize influenza, RSV, and COVID-19. This lack of specific identification can lead to 'non-specific viral respiratory illness' diagnoses, obscuring the true burden of these pathogens. Parents must remain vigilant, understanding that both PIV and HMPV can cause severe acute respiratory illness, including croup, bronchiolitis, and pneumonia, especially in vulnerable young children. The CDC continues to monitor these trends, emphasizing the importance of recognizing symptoms like a barking cough, wheezing, and difficulty breathing, and knowing when to seek immediate medical attention. While specific antiviral treatments are largely unavailable, supportive care remains critical to manage symptoms and prevent complications.